TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: A randomised clinical trial protocol

BMJ Open

Volumn 8, Issue 1, 2018, Pages

  Chow, Clara K ^a,b,c   Thiagalingam, Aravinda ^a,b,c   Santo, Karla ^a   Kok, Cindy ^a,c   Thakkar, Jay ^a,b,c   Stepien, Sandrine ^a,c   Billot, Laurent ^a,c   Jan, Stephen ^a,c   Joshi, Rohina ^a,c   Hillis, Graham S ^d   Brieger, David ^a,e   Chew, Derek P ^f   Rådholm, Karin ^g   Atherton, John J ^h   Bhindi, Ravinay ⁱ   Collins, Nicholas ^j   Coverdale, Steven ^k   Hamilton Craig, Christian ^l   Kangaharan, Nadarajah ^m,n   Maiorana, Andrew ^o   McGrady, Michelle ^p   Shetty, Pratap ^q   Thompson, Peter ^r   Rogers, Anthony ^a,c   Redfern, Julie ^a,b,c   more..

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e ANZAC Research Institute   (Australia)

^f FLINDERS UNIVERSITY   (Australia)

^g LINKÖPING UNIVERSITY   (Sweden)

^h ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

ⁱ ROYAL NORTH SHORE HOSPITAL   (Australia)

^j JOHN HUNTER HOSPITAL   (Australia)

^k Sunshine Coast University Hospital   (Australia)

^l UNIVERSITY OF QUEENSLAND   (Australia)

^m ROYAL DARWIN HOSPITAL   (Australia)

ⁿ ALICE SPRINGS HOSPITAL   (Australia)

^o CURTIN UNIVERSITY   (Australia)

^p ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^q WOLLONGONG HOSPITAL   (Australia)

^r SIR CHARLES GAIRDNER HOSPITAL   (Australia)

more..

Author keywords

cardiovascular risk factors; coronary heart disease; medication adherence; mhealth; secondary prevention; text message

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE CORONARY SYNDROME; ALL CAUSE MORTALITY; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIASTOLIC BLOOD PRESSURE; ECONOMIC ASPECT; EXERCISE; FOLLOW UP; HEALTH EDUCATION; HEALTHY DIET; HEART PROTECTION; HEART REHABILITATION; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; MEDICATION COMPLIANCE; MOTIVATION; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT RISK; PROGRAM ACCEPTABILITY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; SINGLE BLIND PROCEDURE; SMOKING CESSATION; SOCIAL SUPPORT; SYSTOLIC BLOOD PRESSURE; TEXT MESSAGING; TREATMENT DURATION; TREATMENT INDICATION; BLOOD; BLOOD PRESSURE; CLINICAL TRIAL; DIET; FEMALE; HEALTH PROMOTION; LIFESTYLE; MALE; METHODOLOGY; MOBILE PHONE; PATIENT EDUCATION; PROCEDURES; REMINDER SYSTEM; TELEMEDICINE;

ACUTE CORONARY SYNDROME; BLOOD PRESSURE; CELL PHONE; CHOLESTEROL, LDL; DIET; EXERCISE; FEMALE; HEALTH PROMOTION; HUMANS; LIFE STYLE; MALE; MEDICATION ADHERENCE; MOTIVATION; PATIENT EDUCATION AS TOPIC; PATIENT READMISSION; REMINDER SYSTEMS; RESEARCH DESIGN; RISK FACTORS; SECONDARY PREVENTION; SINGLE-BLIND METHOD; TELEMEDICINE; TEXT MESSAGING;

EID: 85051974512     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2017-019463     Document Type: Article

References (45)

1. Organisation WH. The top 10 cause of death. Fact Sheet No 310. (accessed may 2014).
2. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 2015;131:e29-322.
3. Clark AM, Hartling L, Vandermeer B, et al. Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann Intern Med 2005;143:659-72.
4. Clark AM, Haykowsky M, Kryworuchko J, et al. A meta-analysis of randomized control trials of home-based secondary prevention programs for coronary artery disease. Eur J Cardiovasc Prev Rehabil 2010;17:261-70.
5. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
6. LaRosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA 1999;282:2340-6.
7. Turnbull F, Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003;362:1527-35.
8. Taylor RS, Brown A, Ebrahim S, et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 2004;116:682-92.
9. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 2007;297:177-86.
10. Pearson TA, Blair SN, Daniels SR, et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 2002;106:388-91.
11. Smith SC, Benjamin EJ, Bonow RO, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 2011;124:2458-73.
12. Kerr AJ, Broad J, Wells S, et al. Should the first priority in cardiovascular risk management be those with prior cardiovascular disease? Heart 2009;95:125-9.
13. Briffa TG, Hobbs MS, Tonkin A, et al. Population trends of recurrent coronary heart disease event rates remain high. Circ Cardiovasc Qual Outcomes 2011;4:107-13.
14. Organization WH. Adherence to long-term therapies: evidence for action. Geneva, Switzerland, 2003. http://wwwwhoint/chronic conditions/adherencereport/en/
15. Sustainable development goals 17 goals to transfer our world. 2017. http ://w ww.u n.org/ sustainabledev elo pmen t/ health/
16. Santo K, Kirkendall S, Laba TL, et al. Interventions to improve medication adherence in coronary disease patients: a systematic review and meta-analysis of randomised controlled trials. Eur J Prev Cardiol 2016;23:1065-76.
17. Chow CK, Redfern J, Hillis GS, et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA 2015;314:1255-63.
18. Vodopivec-Jamsek V, de Jongh T, Gurol-Urganci I, et al. Mobile phone messaging for preventive health care. Cochrane Database Syst Rev 2012;12:Cd007457.
19. Lester RT, Ritvo P, Mills EJ, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet 2010;376:1838-45.
20. Patrick K, Raab F, Adams MA, et al. A text message-based intervention for weight loss: randomized controlled trial. J Med Internet Res 2009;11:e1.
21. Franklin VL, Waller A, Pagliari C, et al. A randomized controlled trial of Sweet Talk, a text-messaging system to support young people with diabetes. Diabet Med 2006;23:1332-8.
22. Petrie KJ, Perry K, Broadbent E, et al. A text message programme designed to modify patients' illness and treatment beliefs improves self-reported adherence to asthma preventer medication. Br J Health Psychol 2012;17:74-84.
23. Márquez Contreras E, de la Figuera von Wichmann M, Gil Guillén V, et al. [Effectiveness of an intervention to provide information to patients with hypertension as short text messages and reminders sent to their mobile phone (HTA-Alert)]. Aten Primaria 2004;34:399-405.
24. Measuring the Information Society Report. 6th edn: ITU, 2014.
25. Thakkar J, Kurup R, Laba TL, et al. Mobile telephone text messaging for medication adherence in chronic disease: A meta-analysis. JAMA Intern Med 2016;176:340-9.
26. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Circulation 2012;126:2020-35.
27. Redfern J, Thiagalingam A, Jan S, et al. Development of a set of mobile phone text messages designed for prevention of recurrent cardiovascular events. Eur J Prev Cardiol 2014;21:492-9.
28. Thakkar J, Barry T, Thiagalingam A, et al. Design considerations in development of a mobile health intervention program: The TEXT ME and TEXTMEDS experience. JMIR Mhealth Uhealth 2016;4:e127.
29. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-97.
30. Maddox TM, Ho PM. Medication adherence and the patient with coronary artery disease: challenges for the practitioner. Curr Opin Cardiol 2009;24:468-72.
31. Chow CK, Redfern J, Thiagalingam A, et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open 2012;2:e000606.
32. Oakley A, Strange V, Bonell C, et al. Process evaluation in randomised controlled trials of complex interventions. BMJ 2006;332:413-6.
33. Pawson R, Tilley N. Realistic evaluation. London: Thousand Oaks:Sage, 1997.
34. Drummond M, Sculpher M, Torrance G, et al. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press, 2005.
35. Ware J, Kosinski M, Keller SD. A 12-Item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-33.
36. Clarke PM, Glasziou P, Patel A, et al. Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis. PLoS Med 2010;7:e1000236.
37. Briggs A, Sculpher M, Claxton K. Decision Modelling for Health Economic Evaluation 2006. Oxford: Oxford University Press, 2006.
38. Peterson ED, Roe MT, Mulgund J, et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA 2006;295:1912-20.
39. Chew DP, French J, Briffa TG, et al. Acute coronary syndrome care across Australia and New Zealand: the SNAPSHOT ACS study. Med J Aust 2013;199:185-91.
40. Chow C, Ranasinghe I, Blenkhorn A, et al. Use of secondary prevention medications in patients following admission with acute coronary syndrome in Australia\-The CONCORDANCE Study. Heart, Lung and Circulation 2012;21(Suppl 1):S264.
41. Heeley EL, Peiris DP, Patel AA, et al. Cardiovascular risk perception and evidence-practice gaps in Australian general practice (the AusHEART study). Med J Aust 2010;192:254-9.
42. Organisation WH. Global Physical Activity Questionnaire (GPAQ) analysis guide. 2011. http://wwwwhoint/chp/steps/resources/GPAQ AnalysisGuidepdf
43. v2.1 WSICaE. The WHO STEPwise approach to chronic disease risk factor surveillance (STEPS). Geneva: World Health Organisation, 2008.
44. Spitzer RL, Kroenke K, Williams JB, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006;166:1092-7.
45. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606-13